文献速递肝胆胰外科围术期管理与 ERAS

加速康复路径可改善复杂腹部手术患者结局并控制费用:一项随机对照试验

Enhancing Patient Outcomes while Containing Costs after Complex Abdominal Operation: A Randomized Controlled Trial of the Whipple Accelerated Recovery Pathway.
PubMed 文献 · J Am Coll Surg · 2019-01-17

本研究为随机对照试验,纳入排除高危患者的胰十二指肠切除术患者,比较5天Whipple加速康复路径(WARP)与传统7天路径。WARP显著提高术后第5天出院回家比例(75.7% vs 12.8%,p<0.001),不增加再入院率(8.1% vs 10.3%,p=1.0),并缩短辅助治疗启动时间(51天 vs 66天,p=0.005)和降低住院费用($26,563 vs $31,845,p=0.011)。

要点

  • WARP使术后第5天出院回家比例从12.8%提升至75.7%。
  • WARP不增加再入院率,总体并发症率无差异。
  • WARP缩短辅助治疗启动时间并降低住院费用。

核心结论

  • 在选择的胰十二指肠切除术患者中,WARP可安全缩短住院时间、辅助治疗启动时间和费用,不增加再入院风险。

主要发现

  • WARP组术后第5天出院回家比例为75.7%,对照组为12.8%(p<0.001)。
  • 再入院率WARP组8.1%,对照组10.3%(p=1.0)。
  • 总体并发症率WARP组29.7%,对照组43.6%(p=0.24)。
  • 手术至辅助治疗启动时间WARP组51天,对照组66天(p=0.005)。
  • 住院费用WARP组$26,563,对照组$31,845(p=0.011)。

临床怎么用

  • 对于选择的胰十二指肠切除术患者,可考虑实施WARP以加速康复、缩短住院时间和降低费用。

局限性

  • 试验因中期分析提前终止,实际样本量小于目标入组量。
  • 研究排除了高危患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study was designed to determine whether a standardized recovery pathway could reduce post-pancreaticoduodenectomy hospital length of stay to 5 days without increasing complication or readmission rates. STUDY DESIGN: Pancreaticoduodenectomy patients (high-risk patients excluded) were enrolled in an IRB-approved, prospective, randomized controlled trial (NCT02517268) comparing a 5-day Whipple accelerated recovery pathway (WARP) with our traditional 7-day pathway (control). Whipple accelerated recovery pathway interventions included early discharge planning, shortened ICU stay, modified postoperative dietary and drain management algorithm, rigorous physical therapy with in-hospital gym visit, standardized rectal suppository administration, and close telehealth follow-up post discharge. The trial was powered to detect an increase in postoperative day 5 discharge from 10% to 30% (80% power, α = 0.05, 2-sided Fisher's exact test, target accrual: 142 patients). RESULTS: Seventy-six patients (37 WARP, 39 control) were randomized from June 2015 to September 2017. A planned interim analysis was conducted at 50% trial accrual resulting in mandatory early stoppage, as the predefined efficacy end point was met. Demographic variables between groups were similar. The WARP significantly increased the number of patients discharged to home by postoperative day 5 compared with controls (75.7% vs 12.8%; p < 0.001) without increasing readmission rates (8.1% vs 10.3%; p = 1.0). Overall complication rates did not differ between groups (29.7% vs 43.6%; p = 0.24), but the WARP significantly reduced the time from operation to adjuvant therapy initiation (51 days vs 66 days; p = 0.005) and hospital cost ($26,563 vs $31,845; p = 0.011). CONCLUSIONS: The WARP can safely reduce hospital length of stay, time to adjuvant therapy, and cost in selected pancreaticoduodenectomy patients without increasing readmission risk.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Lavu H, McCall NS, Winter JM, et al. Enhancing Patient Outcomes while Containing Costs after Complex Abdominal Operation: A Randomized Controlled Trial of the Whipple Accelerated Recovery Pathway. J Am Coll Surg. 2019. PMID: 30660818. doi:10.1016/j.jamcollsurg.2018.12.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。